Biopharmas raising money in public or private financings, including: Akari, Nuvation.

Biopharmas raising money in public or private financings, including: Innocan.

Antibody-drug conjugate developer Duality Biotherapeutics Inc. is gearing up for a second IPO attempt this year, having filed on Feb. 27 a new prospectus on the Hong Kong Stock Exchange. Two other biotechs – Genuine Biotech Ltd. and Cloudbreak Pharma Inc. – also are having another go at a listing in Hong Kong in 2025.

Biopharmas raising money in public or private financings, including: PDS Biotechnology.

Biopharmas raising money in public or private financings, including: Biomx, Enveda, Ignota Labs, Moleculin, Renovaro, Sanofi.

Biopharmas raising money in public or private financings, including: Financings: Castle Creek, GT, Ligand, Maia, Paradox.

Biopharmas raising money in public or private financings, including: Blue Water Acquisition, Firefly Neuroscience.

Biopharmas raising money in public or private financings, including: Atai.